The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...

January is a big time for drugmakers to hike prices. This year saw higher prices for 575 medications so far, including ...

The U.S. Federal Trade Commission on Tuesday published the second part of its investigation into how prescription drug ...

The three largest pharmacy benefit managers (PBMs) inflated the price of specialty generic drugs beyond their costs of ...

are often paid 20- to 40-times the National Average Drug Acquisition Cost, and significantly more than unaffiliated pharmacies. This preferential treatment harms independent pharmacies and ...

Included in a so-called “continuing resolution” before Congress is a “provision that would require PBMs to reimburse pharmacies at (National Average Drug Acquisition Cost) plus the state’s ...

consumer or employer and forbid a PBM from paying a reimbursement less than the national average drug acquisition cost, plus a professional dispensing fee. The legislation mandates that contracts ...

Ensuring fair and adequate Medicaid managed care pharmacy reimbursement from PBMs to cover the cost to acquire and dispense prescription drugs. Requiring National Average Drug Acquisition Cost ...

Ensuring fair and adequate Medicaid managed care pharmacy reimbursement from PBMs to cover the cost to acquire and dispense prescription drugs. - Requiring National Average Drug Acquisition Cost ...

Investing.com -- The Federal Trade Commission (FTC) has released a report showing that the three largest pharmacy benefit managers (PBMs) in the industry have significantly marked up prices on ...

METHODS: National STD guidelines, purchasing mechanisms, and drug acquisition costs from 15 countries were compiled, using information from ministries of health and European Commissions headquarters.